1. Czerwińska, Patrycja, Mazurek, Sylwia, Wiznerowicz, Maciej. 2017. The complexity of TRIM28 contribution to cancer. In Journal of biomedical science, 24, 63. doi:10.1186/s12929-017-0374-4. https://pubmed.ncbi.nlm.nih.gov/28851455/
2. Lin, Jianhuang, Guo, Dajiang, Liu, Heng, Helin, Kristian, Zhang, Rugang. . The SETDB1-TRIM28 Complex Suppresses Antitumor Immunity. In Cancer immunology research, 9, 1413-1424. doi:10.1158/2326-6066.CIR-21-0754. https://pubmed.ncbi.nlm.nih.gov/34848497/
3. Park, Han-Hee, Kim, Hwa-Ryeon, Park, Sang-Yeong, Roe, Jae-Seok, Kim, You-Sun. 2021. RIPK3 activation induces TRIM28 derepression in cancer cells and enhances the anti-tumor microenvironment. In Molecular cancer, 20, 107. doi:10.1186/s12943-021-01399-3. https://pubmed.ncbi.nlm.nih.gov/34419074/
4. Liu, Huadie, Liu, Ye, Jin, Seung-Gi, Pfeifer, Gerd P, Yang, Tao. 2023. TRIM28 secures skeletal stem cell fate during skeletogenesis by silencing neural gene expression and repressing GREM1/AKT/mTOR signaling axis. In Cell reports, 42, 112012. doi:10.1016/j.celrep.2023.112012. https://pubmed.ncbi.nlm.nih.gov/36680774/
5. Hol, Janna A, Diets, Illja J, de Krijger, Ronald R, Jongmans, Marjolijn Cj, Kuiper, Roland P. 2021. TRIM28 variants and Wilms' tumour predisposition. In The Journal of pathology, 254, 494-504. doi:10.1002/path.5639. https://pubmed.ncbi.nlm.nih.gov/33565090/